Mgmt Methylated Glioblastoma clinical trials

Explore recruiting mgmt methylated glioblastoma clinical trials.

Recruiting mgmt methylated glioblastoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Mgmt Methylated Glioblastoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy (MecMeth/ NOA-24)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Mgmt Methylated Glioblastoma trials by city

Mgmt Methylated Glioblastoma in Toronto Mgmt Methylated Glioblastoma in Vancouver Mgmt Methylated Glioblastoma in Montreal Mgmt Methylated Glioblastoma in Calgary Mgmt Methylated Glioblastoma in Edmonton Mgmt Methylated Glioblastoma in Ottawa Mgmt Methylated Glioblastoma in Winnipeg Mgmt Methylated Glioblastoma in Quebec City Mgmt Methylated Glioblastoma in Hamilton Mgmt Methylated Glioblastoma in Kitchener Mgmt Methylated Glioblastoma in London Mgmt Methylated Glioblastoma in Halifax Mgmt Methylated Glioblastoma in New York Mgmt Methylated Glioblastoma in Los Angeles Mgmt Methylated Glioblastoma in Chicago Mgmt Methylated Glioblastoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease